Global Stem Cell Therapy for Osteoarthritis Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Stem Cell Therapy for Osteoarthritis Market
OA is the most common degenerative joint disease. Its initial symptoms include loss of articular cartilage followed by progressive to joint stiffness, swelling, pain, and loss of mobility.

Stem cells are the body's raw materials — cells from which all other cells with specialized functions are generated. Under the right conditions in the body or a laboratory, stem cells divide to form more cells called daughter cells. These daughter cells either become new stem cells (self-renewal) or become specialized cells (differentiation) with a more specific function, such as blood cells, brain cells, heart muscle cells or bone cells. No other cell in the body has the natural ability to generate new cell types.

Most stem cells used for the experimental treatment of OA are adult MSCs. Researchers can easily collect them from fat or bone marrow. MSCs are able to turn into cartilage, bone, muscle, tendon, ligaments, or fat, depending on the type of tissue that surrounds them. This is why researchers are studying MSCs in stem cell treatments for OA.

The global Stem Cell Therapy for Osteoarthritis market size is projected to reach US$ 107.3 million by 2028, from US$ 22 million in 2021, at a CAGR of 25.1% during 2022-2028.

In the global market, the core manufacturers of Stem cell therapy for osteoarthritis include Medipost etc, and the top 1 manufacturer accounts for about 80% of the market share. The market include Asia Pacific and Europe, with a share of 90% and 10%. allogeneic accounted for 90% and autologous accounted for 10%. the product is mainly used in primary osteoarthritis and secondary osteoarthritis fields, with a share of 92% and 8%.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Stem Cell Therapy for Osteoarthritis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Stem Cell Therapy for Osteoarthritis market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Stem Cell Therapy for Osteoarthritis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Stem Cell Therapy for Osteoarthritis market.

Impact of Covid-19 Outbreak

This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.

Segmental Analysis

The report has been segmented into product and application segments. The researchers have documented all the products present today in the Stem Cell Therapy for Osteoarthritis market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.

Stem Cell Therapy for Osteoarthritis Breakdown Data by Type

Allogeneic

Autologous

Stem Cell Therapy for Osteoarthritis Breakdown Data by Application

Primary Osteoarthritis

Secondary Osteoarthritis

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Competitive Landscape

This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:

Medipost

Nature Cell

Theracell Advanced Biotechnology

Takeda (TiGenix)

TABLE OF CONTENT

1 Report Business Overview
1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Allogeneic

1.2.3 Autologous

1.3 Market by Application

1.3.1 Global Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Primary Osteoarthritis

1.3.3 Secondary Osteoarthritis

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Stem Cell Therapy for Osteoarthritis Market Perspective (2017-2028)

2.2 Stem Cell Therapy for Osteoarthritis Growth Trends by Region

2.2.1 Stem Cell Therapy for Osteoarthritis Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Stem Cell Therapy for Osteoarthritis Historic Market Size by Region (2017-2022)

2.2.3 Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Region (2023-2028)

2.3 Stem Cell Therapy for Osteoarthritis Market Dynamics

2.3.1 Stem Cell Therapy for Osteoarthritis Industry Trends

2.3.2 Stem Cell Therapy for Osteoarthritis Market Drivers

2.3.3 Stem Cell Therapy for Osteoarthritis Market Challenges

2.3.4 Stem Cell Therapy for Osteoarthritis Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Stem Cell Therapy for Osteoarthritis Players by Revenue

3.1.1 Global Top Stem Cell Therapy for Osteoarthritis Players by Revenue (2017-2022)

3.1.2 Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Players (2017-2022)

3.2 Global Stem Cell Therapy for Osteoarthritis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Stem Cell Therapy for Osteoarthritis Revenue

3.4 Global Stem Cell Therapy for Osteoarthritis Market Concentration Ratio

3.4.1 Global Stem Cell Therapy for Osteoarthritis Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Stem Cell Therapy for Osteoarthritis Revenue in 2021

3.5 Stem Cell Therapy for Osteoarthritis Key Players Head office and Area Served

3.6 Key Players Stem Cell Therapy for Osteoarthritis Product Solution and Service

3.7 Date of Enter into Stem Cell Therapy for Osteoarthritis Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Stem Cell Therapy for Osteoarthritis Breakdown Data by Type

4.1 Global Stem Cell Therapy for Osteoarthritis Historic Market Size by Type (2017-2022)

4.2 Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Type (2023-2028)

5 Stem Cell Therapy for Osteoarthritis Breakdown Data by Application

5.1 Global Stem Cell Therapy for Osteoarthritis Historic Market Size by Application (2017-2022)

5.2 Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Stem Cell Therapy for Osteoarthritis Market Size (2017-2028)

6.2 North America Stem Cell Therapy for Osteoarthritis Market Size by Type

6.2.1 North America Stem Cell Therapy for Osteoarthritis Market Size by Type (2017-2022)

6.2.2 North America Stem Cell Therapy for Osteoarthritis Market Size by Type (2023-2028)

6.2.3 North America Stem Cell Therapy for Osteoarthritis Market Share by Type (2017-2028)

6.3 North America Stem Cell Therapy for Osteoarthritis Market Size by Application

6.3.1 North America Stem Cell Therapy for Osteoarthritis Market Size by Application (2017-2022)

6.3.2 North America Stem Cell Therapy for Osteoarthritis Market Size by Application (2023-2028)

6.3.3 North America Stem Cell Therapy for Osteoarthritis Market Share by Application (2017-2028)

6.4 North America Stem Cell Therapy for Osteoarthritis Market Size by Country

6.4.1 North America Stem Cell Therapy for Osteoarthritis Market Size by Country (2017-2022)

6.4.2 North America Stem Cell Therapy for Osteoarthritis Market Size by Country (2023-2028)

6.4.3 United States

6.4.4 Canada

7 Europe

7.1 Europe Stem Cell Therapy for Osteoarthritis Market Size (2017-2028)

7.2 Europe Stem Cell Therapy for Osteoarthritis Market Size by Type

7.2.1 Europe Stem Cell Therapy for Osteoarthritis Market Size by Type (2017-2022)

7.2.2 Europe Stem Cell Therapy for Osteoarthritis Market Size by Type (2023-2028)

7.2.3 Europe Stem Cell Therapy for Osteoarthritis Market Share by Type (2017-2028)

7.3 Europe Stem Cell Therapy for Osteoarthritis Market Size by Application

7.3.1 Europe Stem Cell Therapy for Osteoarthritis Market Size by Application (2017-2022)

7.3.2 Europe Stem Cell Therapy for Osteoarthritis Market Size by Application (2023-2028)

7.3.3 Europe Stem Cell Therapy for Osteoarthritis Market Share by Application (2017-2028)

7.4 Europe Stem Cell Therapy for Osteoarthritis Market Size by Country

7.4.1 Europe Stem Cell Therapy for Osteoarthritis Market Size by Country (2017-2022)

7.4.2 Europe Stem Cell Therapy for Osteoarthritis Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size (2017-2028)

8.2 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Type

8.2.1 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Share by Type (2017-2028)

8.3 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Application

8.3.1 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Share by Application (2017-2028)

8.4 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Region

8.4.1 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Stem Cell Therapy for Osteoarthritis Market Size (2017-2028)

9.2 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Type

9.2.1 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Type (2017-2022)

9.2.2 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Type (2023-2028)

9.2.3 Latin America Stem Cell Therapy for Osteoarthritis Market Share by Type (2017-2028)

9.3 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Application

9.3.1 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Application (2017-2022)

9.3.2 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Application (2023-2028)

9.3.3 Latin America Stem Cell Therapy for Osteoarthritis Market Share by Application (2017-2028)

9.4 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country

9.4.1 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country (2017-2022)

9.4.2 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size (2017-2028)

10.2 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Type

10.2.1 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Share by Type (2017-2028)

10.3 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Application

10.3.1 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Share by Application (2017-2028)

10.4 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country

10.4.1 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 Medipost

11.1.1 Medipost Company Details

11.1.2 Medipost Business Overview

11.1.3 Medipost Stem Cell Therapy for Osteoarthritis Introduction

11.1.4 Medipost Revenue in Stem Cell Therapy for Osteoarthritis Business (2017-2022)

11.1.5 Medipost Recent Developments

11.2 Nature Cell

11.2.1 Nature Cell Company Details

11.2.2 Nature Cell Business Overview

11.2.3 Nature Cell Stem Cell Therapy for Osteoarthritis Introduction

11.2.4 Nature Cell Revenue in Stem Cell Therapy for Osteoarthritis Business (2017-2022)

11.2.5 Nature Cell Recent Developments

11.3 Theracell Advanced Biotechnology

11.3.1 Theracell Advanced Biotechnology Company Details

11.3.2 Theracell Advanced Biotechnology Business Overview

11.3.3 Theracell Advanced Biotechnology Stem Cell Therapy for Osteoarthritis Introduction

11.3.4 Theracell Advanced Biotechnology Revenue in Stem Cell Therapy for Osteoarthritis Business (2017-2022)

11.3.5 Theracell Advanced Biotechnology Recent Developments

11.4 Takeda (TiGenix)

11.4.1 Takeda (TiGenix) Company Details

11.4.2 Takeda (TiGenix) Business Overview

11.4.3 Takeda (TiGenix) Stem Cell Therapy for Osteoarthritis Introduction

11.4.4 Takeda (TiGenix) Revenue in Stem Cell Therapy for Osteoarthritis Business (2017-2022)

11.4.5 Takeda (TiGenix) Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

Choose License Type

Checkout Inquiry Sample